Shares of Glenmark Pharmaceuticals fell as much as 4.7% on Monday, after the drug maker’s Q1 profit tanked. Glenmark ...

On a lively weekend, a bartender in Nepal's capital Kathmandu balances carefully a slice of titaura, a local tangy and spicy hog plum treat, on top of a martini glass.The drink is an example of how a ...

Columbia Threadneedle’s Q2 2025 report shows all five portfolios beat benchmarks with smart equity and fixed-income calls.

China’s exports of refined products, including diesel, gasoline, aviation fuel, and marine fuel, rose 7.1% year on year to ...

Christopher Wood of Jefferies has urged investors to buy Indian equities despite tariff threats from US President Donald ...

The Trump-Putin meeting has raised hopes of easing geopolitical tensions and tariff relief, particularly for emerging ...

As Connor McDavid enters the final year of his contract with the Edmonton Oilers, speculation swirls about his future. While ...

B2B fintechs are increasingly turning to the consumer side of the payments market, using third-party UPI applications (TPAPs) ...

As the crypto market heads into what could be its most explosive growth cycle yet, smart investors are focusing on the top ...

Bitcoin is on the right track for a potential surge to $150,000 in 2025, fueled by growing institutional adoption, regulatory readability, and increasing ETF-ba ...

Emerging-market funds are pivoting to capture the artificial intelligence craze, with some investors predicting that booming ...

AngioDynamics has transformed into a focused MedTech player with rising sales, positive EBITDA, and strong growth drivers.